A 2-Biomarker Model Augments Clinical Prediction of Mortality in Melioidosis.

MLA

Wright, Shelton W., et al. “A 2-Biomarker Model Augments Clinical Prediction of Mortality in Melioidosis.” Clinical Infectious Diseases, vol. 72, no. 5, Mar. 2021, pp. 821–28. EBSCOhost, https://doi.org/10.1093/cid/ciaa126.

APA

Wright, S. W., Kaewarpai, T., Lovelace-Macon, L., Ducken, D., Hantrakun, V., Rudd, K. E., Teparrukkul, P., Phunpang, R., Ekchariyawat, P., Dulsuk, A., Moonmueangsan, B., Morakot, C., Thiansukhon, E., Limmathurotsakul, D., Chantratita, N., & West, T. E. (2021). A 2-Biomarker Model Augments Clinical Prediction of Mortality in Melioidosis. Clinical Infectious Diseases, 72(5), 821–828. https://doi.org/10.1093/cid/ciaa126

Chicago

Wright, Shelton W, Taniya Kaewarpai, Lara Lovelace-Macon, Deirdre Ducken, Viriya Hantrakun, Kristina E Rudd, Prapit Teparrukkul, et al. 2021. “A 2-Biomarker Model Augments Clinical Prediction of Mortality in Melioidosis.” Clinical Infectious Diseases 72 (5): 821–28. doi:10.1093/cid/ciaa126.